Form 4: Guardant Health's Chief Medical Officer Craig Eagle Reports Stock Transactions
SEC Form 4 Filing
Craig Eagle, Chief Medical Officer of Guardant Health, reports the vesting and disposal of restricted stock units to cover tax obligations.
Summary
- On October 1, 2024, Craig Eagle, the Chief Medical Officer of Guardant Health, Inc., engaged in transactions involving the company's stock.
- These transactions included the vesting of restricted stock units (RSUs) and the subsequent disposal of some shares to cover tax withholding obligations.
- Specifically, 1,715 shares vested from an RSU award granted on November 7, 2022, and 6,569 shares vested from an RSU award granted on December 13, 2023.
- A total of 4,200 shares were disposed of at a price of $22.12 to satisfy tax liabilities.
- Following these transactions, Eagle directly owns 23,271 shares of common stock and holds 13,713 and 13,338 restricted stock units from the 2022 and 2023 grants respectively.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Positives
- The vesting of restricted stock units indicates that performance milestones or time-based vesting requirements have been met.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency in insider trading.
- The vesting schedules described are typical for RSU grants, often tied to continued employment and performance milestones.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they primarily reflect the vesting of previously granted equity compensation and the related tax obligations.
Key Dates
| Date | Description |
|---|---|
| 2022-11-07 | Date of restricted stock unit award grant that vests over a four-year period. |
| 2023-12-13 | Date of restricted stock unit award grant that vests over a three-year period. |
| 2023-10-01 | 25% of the shares subject to the November 7, 2022 award vests. |
| 2024-10-01 | Transactions reported: Vesting of RSUs and disposal of shares for tax obligations; 33% of the shares subject to the December 13, 2023 award vests. |
| 2024-10-02 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.